NDC 68180-952 - Triamcinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-952
- Package NDCs from labels
- 68180-952-01, 68180-952-02
- Manufacturer
- Lupin Pharmaceuticals, Inc. | Lupin Atlantis Holdings SA | LUPIN LIMITED
- Effective date
- 2020-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamcinolone Acetonide Cream USP Rx only | Lupin Pharmaceuticals, Inc. | Lupin Atlantis Holdings SA | LUPIN LIMITED | 2020-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-952-01 | Triamcinolone Acetonide | 15 g in 1 TUBE | CREAM | 15 | 3 | |
| 68180-952-01 | Triamcinolone Acetonide | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 68180-952-02 | Triamcinolone Acetonide | 80 g in 1 TUBE | CREAM | 80 | 3 | |
| 68180-952-02 | Triamcinolone Acetonide | 1 in 1 CARTON | CREAM | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals,Inc. | bd45c7d2-a1a3-e0f5-e053-2a95a90ae4b3 | 2026-02-19 | Adverse reactions | 1085644 F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals,Inc. | bd465674-3527-1590-e053-2995a90a958d | 2026-02-19 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 96f18791-480d-49f2-aac6-387321ae552c | 2026-02-14 | Adverse reactions | 1014314 1085644 F446C597KA |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| iShanCare Vaginal Antibacterial Gel | ISHANCARE VAGINAL ANTIBACTERIAL GEL | Shenzhen Ishan Technology Co., Ltd | 254a6624-80b6-b089-e063-6294a90a887e | 2026-02-12 | Warnings | 33X04XA5AT |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Amneal Pharmaceuticals LLC | c38dcd37-9840-4f71-a5c9-97380c8107f2 | 2026-02-12 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | A-S Medication Solutions | 51fedf94-d94e-42b7-8e9f-e0e9b6bbd055 | 2026-02-11 | Adverse reactions | 1014314 F446C597KA |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | 4e0ddecf-7ea1-4f42-9924-53fe5a5657ff | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ASCLEMED USA INC. | 1c6a740e-bc0d-41f3-b576-7d4c3880be23 | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | c76d68dc-78e6-407c-ba9d-5d1c5d13509e | 2026-02-05 | Adverse reactions | 1014314 F446C597KA |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.